Publicaciones (27) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. Assessment of Quality of Life and Treatment Outcomes of Patients with Persistent Postchemotherapy Alopecia

    JAMA Dermatology, Vol. 155, Núm. 6, pp. 724-728

  2. Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: A post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

    Cardiovascular Diabetology, Vol. 18, Núm. 1

  3. Churg-Strauss syndrome and pregnancy. Case report and bibliographic review.

    Ginecologia y Obstetricia de Mexico, Vol. 87, Núm. 11, pp. 756-761

  4. Clinical Characterization of Immunotherapy-Related Pruritus among Patients Seen in 2 Oncodermatology Clinics

    JAMA Dermatology

  5. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials

    Diabetes and Metabolism, Vol. 45, Núm. 5, pp. 409-418

  6. Cost of achieving hba1c and weight loss treatment targets with ideglira vs insulin glargine u100 plus insulin aspart in the usa

    ClinicoEconomics and Outcomes Research, Vol. 11, pp. 271-282

  7. Cryosurgical management of basal cell carcinoma: in vivo follow-up using reflectance confocal microscopy

    International Journal of Dermatology

  8. Document on a comprehensive approach to type 2 diabetes mellitus

    Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 7, pp. 443-458

  9. Déficit de vitamina D en medicina deportiva: recomendaciones en la práctica clínica

    Faes Farma

  10. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial

    JACC: Cardiovascular Imaging, Vol. 12, Núm. 7, pp. 1188-1198

  11. Effect of liraglutide on cardiovascular outcomes in elderly patients: A post hoc analysis of a randomized controlled trial

    Annals of Internal Medicine

  12. Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 6, pp. 1506-1512

  13. Hair disorders in cancer survivors

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1199-1213

  14. Hair disorders in patients with cancer

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1179-1196

  15. IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy

    Diabetes, Obesity and Metabolism, Vol. 21, Núm. 12, pp. 2643-2650

  16. Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

    International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001

  17. In-vivo assessment of a case of cutaneous sarcoidosis using reflectance confocal microscopy

    Anais Brasileiros de Dermatologia, Vol. 94, Núm. 1, pp. 93-95

  18. Nonmelanoma skin cancer in childhood and young adult cancer survivors previously treated with radiotherapy

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 17, Núm. 3, pp. 237-243

  19. Nuevos abordajes en la epiduroscopia para el síndrome de cirugía lumbar fallida. Nuevas oportunidades

    Revista de la Sociedad Espanola del Dolor

  20. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911